Enhanced antigen presentation in the absence of the invariant chain endosomal localization signal by unknown
unng biosynthesis, MHC class II molecules are associated
intracellularlywith a glycoprotein called invariant chain
(Ii) . This association occurs soon after translation of the a
and a chains of the class II heterodimer in the rough en-
doplasmic reticulum (ER)' and the complex remains intact
throughout Golgi apparatus transport. In a post-Golgi ap-
paratus compartment, possibly in the same endosomal com-
partment where antigen is degraded, Ii dissociates from class
II in a protease-dependent fashion, and the majority of class
II appears at the cell surface free of Ii (1, 2). Recently, several
functions have been ascribed to Ii that might affect the gener-
ation of class II-peptide complexes. Ii has been shown to in-
terfere with peptide-class II association (3-5) and to facili-
tate classII folding and egress from the ER (6--10), suggesting
that Ii may act as a surrogate peptide in the ER to allow
proper class II folding and to prevent class II from loading
with peptide early in biosynthesis. In addition, Ii has been
implicated in localizing classII into endosomal compartments
that are thought to be the sites for exogenous antigen pro-
cessing (11-14). This endosomal localization signal resides
within the cytosolic domain of Ii (11, 12). When wild type
Ii is expressed in the absence ofclassII, it is retained intracel-
lularly, apparently localized in the ER and in peripheral vesicles.
Truncation of the rytosolic NH2 terminus eliminates the
t Abbreviation used in this paper. ER, endoplasmic reticulum.
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Summary
The cytosolic tail of the major histocompatibility complex class II-associated invariant chain
(Ii) molecule is thought to contain the endosomal localization signal that directs and/or retains
newly synthesized class II within the endosomal antigen processing compartment. To determine
the role ofthis signal in classII transport and antigen presentation we have generated class II-positive
L cell transfectants that coexpress wild type or truncated forms of Ii. Deletion of the endosomal
localization signal from Ii results in rapid transport of class II-Ii complexes to the cell surface.
Once at the cell surface, the complex is efficiently internalized, Ii is degraded, and class II free
of Ii is recycled back to the plasma membrane. Interestingly, the truncated form of Ii is still
able to increase the efficiency of antigen presentation to T cells. These data suggest that the
ability of Ii to enhance antigen presentation is not limited to Golgi apparatus-endosomal sorting
and raise the possibility that endocytosed class II can form immunogenic complexes with newly
processed antigen.
steady state endosomal localization of Ii and results in the
transport of Ii to the cell surface.
These results demonstrate that Ii can have profound effects
on class II folding and transport and predict that association
with Ii couldincrease the opportunity for class II to associate
with peptides generated in endosomal compartments. Ii has
been shown to increase the efficiency of antigen presentation,
but for only a subset of antigens (15, 16). Although the char-
acteristics of protein antigens that determine Ii dependence
are not known, the ability of class II to present some an-
tigens in the absence of Ii suggests that classII can gain access
to endosomal compartments independently of Ii. Class II could
enter endosomes either by direct transport from the trans-
Golgi network (Chervonsky, A., and A. J. Sant, personal
communication) or after internalization of class II from the
plasma membrane (17-19). In most cases the ability of Ii to
enhance antigen presentation is restricted to the alternatively
spliced Ii gene product, p41 (16). The p41 form of Ii differs
from p31 by the inclusion of an additional exon that encodes
a 64-amino acid segment near the COOH terminus of Ii
(20). The p41 form of Ii is able to impart the same folding
(16) and peptide blocking functions as does p31 (Anderson,
M. S., and J. Miller, manuscript in preparation) . Because p31
and p41 only differ in the lumenal domain, both proteins
contain the same endosomal localization signal located in the
rytosolic tail. Nevertheless, efficient antigen presentation often
requires association of class II with p41 (16) .
As a first step in dissecting the mechanism by which p41
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the endosomal localization signal in the cytosolic tail of Ii
is required. We find that deletion of the cytosolic tail of Ii
does not eliminate the ability of p41 to enhance antigenpre-
sentation. Biochemical analyses ofclass II associated with trun-
catedIi demonstrate that this complexis rapidly transported
to thecell surface and then slowly internalized, allowing for
Ii dissociation and classII-peptide loading. These data estab-
lish a pathway for class II recycling and raise the possibility
that class II may access intracellular peptide loading com-
partments after internalization from the cell surface.
Materials and Methods
Oligonucleotide-directedMutagenesis.
￿
A DNA fragment encoding
the amino terminus of Ii with amino acids 2-17 deleted wasgener-
ated by PCRusing amutagenic24-base oligonucleotidecontaining
the5' untranslated region and thetranslation initiation codon spliced
directly to codons for residues 18-21 of murine Ii and a 18-base
oligonucleotide corresponding to residues 81-86. ThePCRproduct
was subcloned into murine p31 and p41 cDNA clones to generate
pcEXVA2-17p31 and pcEXV-A2-17p41 and theconstructs were
confirmed by dideoxynucleotide sequencing.
Reagents.
￿
The mAb 10.2.16 (21) is specific for I-Ak, MKD6
(22) for I-Ad, M5/114 (23) for I-Ad, P4H5 (24) for murine Ii, 16-
1-11N (25) for class I Kk, and the rabbit antisera a-IiC for the
COOH terminus of murine Ii (provided by Drs. J. Lipp and B.
Doberstein, European Molecular BiologyLaboratory, Heidelberg,
Germany). The rabbit antisera 889, specific fora nonpolymorphic
peptide sequence of thecytosolic tail of theI-A(3chains,was gener-
ated by immunization with the peptide sequence CQKGPRGPP-
PAGLLQ (I-Aa COOH-terminal sequence with a NHZ-terminal
cysteine) coupled to KLH as described (26).
Cell Culture and Transfection.
￿
The I-Al-restricted T cell hybrid-
omas 3A9, specific for hen egg lysozyme (27); TS12, specific for
bovine ribonuclease (28); and SKK45.10, specific for KLH (29);
and the I-Ad-restricted T cell hybridomas 3DO-54.8 and 3DO-
18.3, specific for different peptides of OVA (30), were maintained
in RPMI supplementedwith 10% FCS,10 mM Hepes, 2mM gluta-
mine, 0.1 mM nonessential amino acids, and 50,uM 2-ME. Class
II-positive Ltk- cells expressing no Ii, wild type Ii (16), or trun-
cated Ii were generated as described (16, 31) and maintained in
DMEM supplemented with 10%FCS,10 mM Hepes, 2 mM gluta-
mine, 0.1 mM nonessential amino acids, 200 Wg/ml G418, 250
Etg/ml xanthine, 15 ug/mlhypoxanthine, and6 ug/mlmycophenolic
acid. Because cell surface forms of Ii are sensitive to trypsin con-
centrations required to remove the Ltk- cells from tissue culture
dishes, the L cell transfectants used in these studies were main-
tained as suspension cultures by plating on bacterial petri dishes.
To assay their ability to present antigen, L cell transfectants were
plated at 2.5 x 10° cells per well with T cell hybridomas at 5 x
10" cells per well with antigen for 24 h at 37°C. Lymphokine
production was assayed by [3H]thymidine incorporation into the
IL-2-dependent T cell line, CTLL, incubatedin thepresence of 25%
culture supernatant.
Radiolabeling and Immunoprecipitation.
￿
Cells were preincubated
in leucine-free MEM for1 hat 37°C,pulselabeledwith 300 UCi/ml
of 3H-leucine, and then chased in complete media for various times
at 37°C. For the trypsin experiments, afterthechase time thecells
were chilled on ice, washed with PBS, and incubated with or
without ice cold 0.05% trypsin/0.53 mM EDTA (GIBCO BRL,
Gaithersburg, MD) for 30 min on ice. Ice-cold media containing
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10% FCS was added to inhibit the trypsin reaction and the cells
were washed in PBS. Forcell surface labeling, viable cells (5 x 106)
were isolated on Ficoll gradients, washed in PBS, and 125I-labeled
using the lactoperoxidase method. Labeled cells were solubilized,
lysateswere precleared, andimmunoprecipitation carriedout as de-
scribed (8). For the preclear experiment, lysates were precleared
six timeswith the 889 sera,with the cx-IiC sera, or with acontrol
of normal rabbit sera mixed with 16-1-11N (anti-class I mAb) and
then precipitated with either 889 or tx-IiC. Immunoprecipitates
were washed, eluted in SDS with 2-ME, and analyzed on 10%
polyacrylamide-SDS gels as described (8). Gels wereprocessedwith
EN3HANCE (NEN, Boston, MA), dried, and autoradiographed.
Endocytosis Assay. The endocytosis assay was adapted from
BretscherandLutter (32) andmodified as described (33, 34). Briefly,
N8 x 105 cells, plated in 60-cm dishes the day before the assay,
were washed in cold PBS supplemented with 0.1 mM CaCl2 and
1 MM MgCIZ PBS-CM. Surface proteins were biotinylated with
1.5 mg/ml NHS-SS-Biotin (Pierce, Rockford, IL) in PBS-CM for
30 minon ice andthe reaction was quenched by washing thecells
with ice cold 50-mM glycine in PBS-CM. Parallel plates of cells
were either kept at 4°C or incubatedin prewarmedmedia for var-
ious times at 37°C to allow for internalization of labeled surface
molecules. Internalizationwasstoppedby addition oficecold media.
Cells were then treated with or without 50-mM glutathione to
remove biotin molecules remaining on the cell surface. Cells were
lysedandclassIandclassII MHC moleculeswere successively im-
munoprecipitated with themAb 16-1-11N and10.2-16, respectively.
Immunoprecipitates were electrophoresed on 10 or 12 .5% poly-
acrylamide-SDS gels under nonreducing conditions andtransferred
to nitrocellulose. Theblotswere incubated1-4 hat room tempera-
ture with blocking buffer (3% BSA, 0.5% Tween-20, 1 MD-glu-
cose, 10% glycerol in PBS-CM) followed by 1-4 h with 0.5 x
106 cpm/ml 121I-streptavidin (Amersham Corp., Arlington, IL) in
blocking buffer to detect biotinylated proteins. Theblotswere then
washed repeatedly with 0.5% Tween-20, dried, and autoradi-
ographed. For quantitation, optical densitometry was performed
on films using an AMBIS image acquisition and analysis system
(San Diego, CA).
Results
Deletion of the Endosomal Localization Signalfrom the Cyto-
solic Tail of Ii Results in Expression of Class 77-Ii Complexes
at the Cell Surface. Recent studies have indicated that local-
izationandretentionofclassII within apost-Golgi apparatus,
endosomal compartment is enhanced by association with Ii
(13, 14, 35). This endosomal localization signal within Ii is
thought to reside within thecytosolic tail of Ii, betweenamino
acids 11 and 15 (11, 12). To investigate the importance of
this region of Ii on class II transport and antigen presenta-
tion, I-Ak- and I-Ad-positive Ltk- transfectants expressing
Ii deletedofaminoacids 2-17 (02-17; see Fig. 1) were gener-
ated. Cells transfected with the truncated form of Ii express
significant levels of Ii at thecell surface whilecells expressing
wild type Ii do not (Table 1).
To determine whether A2-17 p41 is expressed at the cell
surface in association with class II, transfectants expressing
wild type andtruncated Ii were cell surface radiolabeled, lysed,
and class II and Ii were immunoprecipitated (Fig. 2). In cells
transfected with thetruncatedform of Ii, class II was coprecipi-
tated with the Ii-specific mAb and A2-17 p41 was coprecipi-Figure 1 .
￿
The NHZ-terminal deletion construct of Ii. Murine Ii exists
as two distinct forms, p31 and p41, that differ by the inclusion in p41
of a 64-amino acid segment (hatched bar) encodedby an alternately spliced
exon (20) . Both p31 and p41 are transmembrane glycoproteins oriented
such that the NHZ terminus resides in the cytosol . The sequence of the
wild type and NHZ-terminal deletion construct (A2-17) of p31 and p41
Ii is shown at the bottom . The A2-17 construct is missing the critical
amino acid residues between 11 and 15 that are necessary for endosomal
localization of Ii (11, 12) . Note that the endosomallocalization signal and
the p41-specific segment required for efficient antigen presentation are lo-
cated on opposite sides of the membrane.
tated with the class II-specific mAb, clearly indicating that
A2-17 p41-class II complexes are present at the cell surface.
In wild type Ii-positive transfectants, Ii was not detectable
at the cell surface in either anti-Ii or anti-class II immuno-
precipitates, confirming that class II dissociates from wild
type Ii before it reaches the cell surface . Both A2-17 p31 and
A2-17 p41 remain associated with class II at the plasma mem-
brane in a manner that effectively inhibits presentation ofpep-
Table 1.
￿
Truncation of Cytosolic Tail of Ii Results in Cell
Ii-negative, class II-positive Ltk- transfectants expressing I-Ak (LAK)
or I-Ad (LAD) were retransfected with a genomic clone of Ii (gIi) that
expresses both p31 and p41, or withcDNA clones expressing either wild
type (p31 or p41) or truncated (A2-17 p31 or A2-17 p41) Ii . The cloned
transfectants were stained with P4H5 (anti-li), MKD6 (anti-I-Ad), or
10.2.16 (anti-I-Ak) followed by FITC-coupled goat anti-mouse IgG
(GaM) and analyzed by flow cytometry . Background staining was de-
termined by staining with the GaM reagent alone . Numbers indicate
the mean fluorescence intensity for each antibody.
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Figure 2 .
￿
A2-17 p41 is expressed at the cell surface associated with class
II . L cell transfectants expressing I-Ak with A2-17 p41 Ii (Ap41), I-Ak with
genomic Ii (gIi), or I-Ad with genomic Ii (LADgli) were surface labeled
with 1251 . I-Ak was immunoprecipitated with 10.2.16, I-Ad with M5/114,
and Ii with P4H5, and analyzed by SDS/PAGE. Class II a chains do not
generally label well with iodine ; however, when associated with Ii, the
labeling efficiency ofa isincreased. Theposition ofmolecular mass markers,
class II a and 0 chains, A2-17 p41 Ii, and the p55 protein that coprecipi-
tates with I-Ak, but not with I-Ad, are indicated.
tide antigens to T cells (reference 5; Anderson, M . S. and
J . Miller, manuscript in preparation) . These results demon-
strate that deletion of the endosomal localization signal in
the cytosolic tail of Ii interferes with the post-Golgi apparatus
processing events that are necessary for Ii degradation and
dissociation from class II before transport of class II to the
cell surface.
Only a Subpopulation of Class 11 Is Associated with A2-17
p41 at the Cell Surface. Reciprocal preclear experiments (Fig.
3) indicate that although the vast majority of cell surface A2-
17 p41 is associated with class II, -30-45% of the total class
II at the cell surface was free of Ii . This population ofli-free
class II was not derived from cells that have turned off A2-17
Ii expression because flow cytometry analysis (summarized
in Table 1) indicates that these transfectants are quite uni-
form in their expression of A2-17 Ii. Although we cannot
exclude the possibility that some class II molecules have not
associated with Ii during biosynthesis, pulse chase analyses
(see next section) argue against this accounting for such a
large percentage of Ii-free class II at the cell surface . These
analyses indicate that a sizable population of cell surface class
II has dissociated from Ii in cells expressing A2-17 p41.
Surface Expression of Ii
Cell line GaM P4H5 10.2.16
LAK 5 5 618
LAK p41 4 6 570
LAK A2-17 p41 8 140 437
GaM P4H5 MKD6
LAD 4 5 446
LAD gIi 5 6 594
LAD p31 5 6 376
LAD p41 6 6 392
LAD A2-17 p31 5 68 437
LAD A2-17 p41 5 62 376Figure 3.
￿
Only a subpopulation ofclass II expressed at the cell surface
is associated with A2-17 p41 . L cell transfectants expressing I-Ak plus A2-
17 p41 Ii were surface labeled with 1251 . Ii-free class II complexes were
detected by preclearing lysates with txliC followed by immunoprecipita-
tion with the class II-specific sera (889) . Class II-free Ii complexes were
detectedby preclearing lysates with 889 followedby immunoprecipitation
with the Ii-specific sera (a-HC) . To determine total class 11 or li, lysates
were precleared with a cocktail of anti-class ImAb and preimmune rabbit
sera (NRS) followed by immunoprecipitation with the class II-specific
or with the Ii-specific antisera . The final preclear from each set was run
in lanes 1, 3, 5, and 7. Class II a and 8 chains, A2-17 p41 Ii, and the
p55 protein that coprecipitates with class II are indicated on the right.
NS is a nonspecific protein that precipitates with the rabbit a-IiC an-
tisera, but not with the mAb tx-Ii, P4H5 (see Fig . 4) .
I-Ak that is free of Ii at the cell surface appears to associate
with a 55-kD protein (p55) . In the preclear experiments (Fig.
3) none of the p55 associated with class II is seen in the anti-
Ii precipitate and all of it remains associated with the Ii-free
class II . Although p55 is readily detected in cell surface-la-
beled cells expressing no Ii (data not shown), wild type Ii,
1962 Antigen Presentation Mediated by Truncated Ii
or truncated (Fig. 2), it is not seen in biosynthetically la-
beled cells (see Fig . 6, below) . This could indicate that p55
is derived from an extracellular source (i.e., serum), that p55
is synthesized at a slow rate, or that p55 is associated with
a very small percentage of class II, but is extremely sensitive
to cell surface labeling. Although the origin of p55 and the
nature of p55 association with I-Ak are not known, several
observations suggest that the interaction is specific . Associa-
tion ofp55 with class II is allele dependent ; p55 is coprecipi-
tated with I-Ak, but not I-Ad using several class II-specific
antibodies, including one antisera that cross-reacts with I-Ak
and I-Ad (Figs. 2 and 3) . Immunoprecipitates of I-Ak from
bothL cell and EL4 cell transfectants contain p55 indicating
that p55-I-Ak association is not cell type specific (data not
shown) . Finally, p55 does not coprecipitate with class I (see
Fig. 6, below) or with transferrin receptor (data not shown) .
Class II-specific, allele-dependent interactions that are blocked
by Ii are characteristic of class II-peptide binding. Because
class II has been shown to form stable complexes with intact
proteins (36), these results suggest that p55 may interact with
the I-Ak-peptide site. Regardless of the nature of p55 associ-
ation with class II, p55 does serve as a useful marker for class
II that has dissociated from Ii (see Fig. 6, below) .
Dissociation ofClass IIfrom Both Wild Type p41 and d2-17
p41 InvolvesProteolytic Cleavage ofli. The pool of li-free class
II at the cell surface raises the possibility that even in the
absence of the endosomal localization signal, class II-Ii dis-
sociation can still occur. To determine where during class II
biosynthesis Ii dissociation might take place, pulse-chase anal-
ysis ofLAK, LAK-p41, and LAK-A2-17 p41 was performed
(Fig. 4) . Both wild type and truncated forms of li associate
with class II early in biosynthesis. The difference in apparent
molecular weight between the two forms of Ii appropriately
reflects the size of the deletion . Based on the relative amount
of Ii coprecipitating with anti-class II reagents, it appears
that most, if not all, class II has associated with Ii early in
Figure 4 . Dissociation of A2-17 p41
from class II is slower than wild type p41 .
L cell transfectants expressing I-Ak alone
(LAK) or in combination with wild type
p41 (LAK p41 Ii) or with A2-17 p41 Ii
(LAK A2-17 p41 Ii) were pulse-labeled for
60 minwith [;H]leucine and chased for 0,
1, 2, 4, 8, or 16 h . Class II was immuno-
precipitated with 10 .2.16 and precipitates
were analyzed by SDS-PAGE. Theposition
ofmolecular mass markers, class II a and
0 chains, A2-17 p41, and the Ii degrada-
tion fragments derived from wildtype p41
(*) and A2-17p41 (* *) that coprecipitate
with class II are indicated.biosynthesis. Class II associated with the truncated form of
p41 matures from the ER through the Golgi apparatus at
a similar rate to class II associated with wild type p41 and
fully processed forms of class II and Ii appear at the 1-h chase
point . The majority of wild type p41 dissociates from class
II shortly after mature glycosylated forms appear at the 1-2-h
chase points . In contrast, A2-17 p41 remains associated with
class II for an extended time and significant dissociation of
A2-17 p41 from class II does not occur until 8 h . Thus, class
II does completely dissociate from both wild type and A2-17
p41, although the process is considerably delayed in cells ex-
pressing the truncated form .
In normal cells, class II-Ii dissociation requires proteolytic
cleavage of Ii, a multi-step process that allows for the isola-
tion of intermediate cleavage products in association with
class II (1, 37, 38) . These fragments are readily detected in
L cell transfectants (asterisk in Fig. 4) without the addition
of protease inhibitors . We are confident that these fragments
represent Ii degradation products because they are not present
in Ii-negative transfectants (Fig. 4) and similar sized fragments
are detected on Western blots with In1, a monoclonal anti-
body that is specific for the cytosolic, NH2 terminus of Ii
(see 16) . Furthermore, these fragments appear concomitantly
with the loss of the intact p41 protein (Fig . 4) . The turnover
of Ii in the wild type transfectant is similar to that described
previously (39) and indicates that class II has gained access
to a late proteolytic compartment that results in the cleavage
of Ii from class II (1, 37, 38) . Dissociation of class II from
the truncated Ii also appears to be proteolytic, as visualiza-
tion of Ii subfragments associated with class II coincides with
Ii dissociation (double asterisk in Fig. 4). The difference in
apparent molecular weight of the Ii subfragments derived
from wild type and A2-17 p41 Ii reflects the predicted size
of the deletion, suggesting that the subfragments derived from
A2-17 p41 are also derived from the NH2 terminus of Ii . Be-
cause deletion of amino acids 2-17 eliminates the In1 epi-
tope, we cannot directly test this possibility. Taken together,
these data indicate that removal of the cytosolic tail ofIi delays
class II-Ii dissociation, but that dissociation still occurs by
cleavage of Ii while it is associated with class II .
Class II Associated with A2-17 p41 Ii Is Rapidly Transported
from the trans-Golgi Apparatus to the Cell Surface. Post-Golgi
apparatus transport of class II to the cell surface is delayed
compared with other integral membrane proteins. During
this delay class II is retained in an Ii-dependent manner in
a cellular compartment that has access to endocytosed mate-
rial (13, 14, 40, 41) . Release of class II from endosomes to
the cell surface requires proteolysis of Ii (35, 42) . To deter-
mine whether class II associated with the truncated form of
Ii was also delayed in transport to the cell surface, we took
advantage of the sensitivity ofIi to various proteases, including
trypsin. Pulse-chase labeledLAK-02-17 p41 cells were treated
with and without trypsin at 4°C before solubilization and
lysates were precipitated with anti-class II antibodies. Sensi-
tivity of Ii to trypsin treatment of intact cells indicates ar-
rival of the class II-Ii complex at the cell surface.
As can be seen in Fig. 5, mature glycosylated forms of ci,
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Figure 5 .
￿
Class II is rapidly transported to the cell surface when as-
sociated with A2-17 p41 . (A) L cell transfectants expressing I-Ak plus A2-
17 p41 Ii were pulse labeled for 30 min with (}H]Ieucine and chased for
0, 0.5, 1, 1.5, 2, and 3 h at 37°C. The cells were moved to 4°C and one
half ofthe cells were incubated with trypsin at 4°C for 30 min . The cells
were lysed, class II was immunoprecipitated with 10 .2.16, and analyzed
by SDS-PAGE. Class II a and 0 chains and A2-17 p41 are indicated on
the right . The position of molecular mass markers are indicated on the
left . (B) Quantitative analysis ofclass II-A2-17 p41 transport is displayed
asO.D. ofAmbis scannedautoradiographs. To compensate for minor differ-
ences in sample loading among lanes, the O.D. of A2-17 p41 has been
normalized to the amount of class II ,B chain in each lane. (Open circles)
ImmatureA2-17 p41 (from pulse chase without trypsin treatment); (filled
circles) mature A2-17 p41 (from pulse chase without trypsin treatment);
(filled squares) plasma membrane A2-17 p41 (amount ofmature A2-17 p41
that is sensitive to trypsin treatment of intact cells determined by sub-
tracting the amount of mature A2-17 p41 with trypsin treatment from
the amount of mature A2-17 p41 without trypsin treatment) .
(3, and A2-17 p41 are first seen by 30 min of chase, and com-
plete conversion of immature to mature proteins takes place
over the next several hours (t1/2 =50 min) . This slow matu-
ration ofclass II-Ii complexes reflects variation in the efficiency
of egress from the ER. Class II-A2-17 p41 complexes aredetected at the cell surface within 60 min, and by 3 h the
vast majority of class II-02-17 p41 complexes have arrived
at the cell surface (6i2 =70 min) . These data indicate that
once glycosylation is complete in the Golgi apparatus, class
II associated with Ii lacking the cytosolic tail is rapidly trans-
ported to the cell surface (tti2 Golgi apparatus to plasma
membrane =20 min) . This is in marked contrast to L cell
transfectants expressing wild type Ii, where transport ofclass
II from the Golgi apparatus to the cell surface is delayed for
ti4-6 hours (Fineschi, B., and J . Miller, manuscript in prep-
aration) .
Analysis of the kinetics ofclass II transport and Ii dissocia-
tion indicates that detectable loss of A2-17 p41 from the
anti-class II precipitates and the appearance of Ii subfragments
occur only after class II-Ii complexes appear at the cell sur-
face. These data suggest that while wild type Ii is degraded
in a post-Golgi network compartment before insertion of
class II into the plasma membrane, A2-17 p41 is degraded
slowly over time and this process does not begin until after
the class II-Ii complex has been transported to the plasma
membrane.
Internalization ofClass IIfrom the Cell Surface .
￿
The finding
that in the A2-17 p41 transfectants Ii degradation occurs only
after the class II-Ii complex has reached the cell surface sug-
gests that this degradation occurs after internalization of the
class II-Ii complex into an endosomal compartment . To mea-
sure class II internalization directly, cells were labeled with
a reducible biotinylation reagent at 4°C, plasma membrane
proteins were allowed to internalize at 37°C for 60 min, and
endocytosed class II molecules were identified by protection
from reduction by glutathione at 4°C . Significant internali-
zation of class II, but not class 1, molecules was observed
(Fig. 6) . Class II associated with both A2-17 p41 and with
p55 were internalized at similar levels . Because class II only
associates with p55 after it has dissociated from Ii (see Fig.
3, above), these results indicate that internalization of class
II from the cell surface is not dependent on association with
A2-17 p41. An endocytic rate constant of 0.52%/min was
calculated for class II-A2-17 p41 complexes by kinetic anal-
ysis of internalization (Fig. 7) . Assuming first order kinetics,
it would take -130 min to internalize 50% of the cell sur-
face class II-02-17 p41 complexes. As the half-life of mature
A2-17 p41 is about 190 min, it would appear that this inter-
nalization rate can account for the slow degradation of A2-
17 p41 .
Taken together the biochemical analysis of class II trans-
port in cells expressing A2-17 p41 suggests that deletion of
the endosomal localization signal of Ii allows for the rapid
transport ofthe class II-li complex to the plasmamembrane.
Once at the cell surface, the class II-02-17 p41 complex is
internalized over time, allowing access to the endosomal com-
partment, where Ii is degraded . Based on the significantly
longer half-life of class II than Ii in A2-17 p41-positive cells
(the half-life for class II degradation from biosynthesis is -15 h
and for A2-17 p41 is ti4 h), Ii-free class II likely recycles to
the plasma membrane. This recycled population could account
for the sizable fraction of Ii-free class II at the cell surface
seen in Fig . 3 .
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Figure 6 .
￿
Class II is spontaneously internalized from the cell surface,
independent of Ii association . L cell transfectants expressing I-Ak plus A2-
17 p41 Ii were biotinylated with NHS-SS-biotin at 0°C and then either
left at 0°C or incubated for 60 min at 37°C . Parallel plates of cells were
then incubated at 0°C with or without glutathione to reduce biotin from
the cell surface. Class I (16 .1.11N) and class II (10.2.16) immunoprecipi-
tates were electrophoresed on SDS/PAGE, transferred to nitrocellulose,
and biotinylated molecules were detected with 1251-avidin . Biotinylated
cell surface molecules that were internalized during the 60-min incuba-
tion at 37°C are protected from reduction by glutathione treatment at
0°C and remain detectable by 1251-avidin binding. The position of class
I heavy chain (Kk) and light chain (02m) are indicated on the left and
the position of class II a and /3 chains, A2-17 p41 Ii, and p55 are indicated
on the right.
Truncatedp41 Ii Can StillEnhance Class II-restricted Antigen
Presentation . Recently, Ii has been shown to facilitate pre-
sentation of only some antigens (15, 16) and this function
is mostly restricted to the alternatively spliced p41 form of
Ii (16) . To determine if the endosomal localization signal in
the cytosolic tail ofIi is critical for the ability ofp41 to facili-
tate antigen presentation, cells expressing no Ii, wild type
p41, or truncated p41 were assayed for presentation of Ii-
Figure 7 .
￿
Class II-02-17 p41 complexes are internalized slowly. L cell
transfectants expressing I-Ak plus A2-17 p41 Ii were biotinylated with
NHS-SS-biotin at 0°C and then either left at 0°C or incubated for 5, 15,
30, or 60 min at 37°C. Internalization was detected as described in Fig .
6 after immunoprecipitation with 10.2.16 (a-class II) mAb . The position
of class IT a and 0 chains, A2-17 p41 Ii, and p55 are indicated on the
right . This experiment was repeated four times with similar results.dependent and li-independent antigens to I-Ak-restricted T
cells (Fig. 8,A-C) . The T cell hybridoma TS12 is insensitive
to enhancement of antigen presentation by wild type Ii, as
both wild type Ii-positive transfectants and Ii-negative trans-
fectants present RNase at equivalent levels to TS12 (Fig . 8
A) . The A2-17 p41 Ii transfectant also presents RNase at
equivalent levels to these cells, suggesting that this mutation
has no apparent effect on the ability of these cells to process
and present native RNase to TS12 . Antigen presentation to
the T cell hybridomas, 3A9 and SKK45 .10, is enhanced by
p41 Ii, as the coexpression of p41 Ii dramatically increases
the efficiency ofantigen presentation over the Ii-negative trans-
fectant (Fig. 8, B and C) . Interestingly, the A2-17 p41 Ii trans-
fectant is able to present native hen egg lysozyme andKLH
at levels equivalent to wild type p41 transfectants (Fig . 8,
B and C) . These results demonstrate that the p41 form of
Ii can enhance antigen presentation independently of the en-
dosomal localization signal located in the cytosolic tail .
When we extended these analyses to I-Ad-restricted T
cells (Fig . 8, D-G), we found that A2-17 p41 inhibited an-
tigen presentation of the Ii-independent epitope recognized
by 3DO54.8 T cells (Fig . 8 D) . Similarly, a truncated form
of p31 Ii, A2-17 p31, can inhibit antigen presentation to the
I-Ad-restricted T cells (Fig. 8, D and G), but not to the
I-Ak-restricted T cells (data not- shown) . Thus, A2-17 p31
g
U
s
U
APC
--~ li-negative
-gli-positive
-+- p41-positive
-A2-17 p41-positive
~- p31-positive
--a- d2-17 p31-positive
(G). The p41-dependent enhancement of antigen presentation is equivalent whether p41 is expressed
a genomic Ii construct or as 100% of total Ii from a p41 cDNA expression vector (F) (16) . RNase,
KLH, keyhole limpet hemocyanin; OVA, chicken ovalbumin.
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and A2-17 p41 have a generalized ability to inhibit antigen
presentation to I-Ad-restricted, but not I-Ak-restricted, T
cells that could reflect the antigens used or the specific T cells
tested . Alternatively, these differences may reflect allelic con-
trol of the avidity of Ii-binding or internalization rates of
class II-Ii complexes . When we tested the ability of t,2-17
p41 to enhance antigen presentation of OVA to 3DO-18.3,
in some (2/6) experiments A2-17 p41 Ii was able to enhance
OVA presentation as well as wild type p41 (Fig. 8 E), how-
ever, in most (4/6) experiments, the truncated p41 was less
efficient than wild type (Fig . 8 F) . These results suggest that
A2-17 p41 can enhance antigen presentation to I-Ad-re-
stricted T cells, but that this effect may be masked by the
ability of A2-17 Ii to inhibit antigen presentation, as seen
for 3DO-54.8 cells . In fact, direct comparison of A2-17 p41
and A2-17 p31-positive cells shows a similar magnitude of
p41-dependent enhancement of antigen presentation to
I-Ad-restricted 3DO-18 .3 T cells as does comparison of wild
type p41- and p31-positive cells (Fig. 8 G) . Because the in-
hibitory effect was not seen with the I-Ak-restricted T cells,
A2-17 p41 Ii consistently was able to enhance antigen pre-
sentation at levels equivalent to wild type p41 . Taken together,
these results indicate that the cytosolic tail of p41 is not re-
quired for enhanced antigen presentation to class II-restricted
T cells .
KLH (Mg/°I)
OVA (vg/ml)
OVA (mg/rtV)
Figure 8.
￿
The endosomal localiza-
tion signal is not required for p41-
dependent enhancement ofantigenpre-
sentation . L cell transfectants expressing
I-Ak (A-C) or I-Ad (D-G) without Ii
(open circles), with genomic Ii (gli,filled
circles), with wild type p41 (filled tri-
angles), with t12-17 p41 (open triangles),
with wild type p31 (filled squares), or
with A2-17 p31 (open squares) were as-
sayed for their ability to present various
doses of antigen to class 11-restricted
T cell hybridomas. Data represent the
incorporation of [ 3H]thymidine (cpm
x 10 3) by the IL-2-dependent T cell
line, CTLL, when cultured in the pres-
ence of 25% culture supernatant from
the antigen presentation assays. Wild
type and truncated forms ofp41 are in-
distinguishable in antigen presentation
of both Ii independent (A) and p41-
facilitated (B and C) antigens to I-Ak-
restricted T cells . Although A2-17 p41
can facilitate I-Ad-restricted antigen
presentation as well as wild type p41
in some experiments (2/6, E), in other
cases (4/6) this enhancement is dimin-
ished (F) . This correlates with the
ability of both A2-17 p31 and A2-17
p41-positive transfectants to inhibit pre-
sentation ofli-independent epitopes to
I-Ad-restricted T cells (D) and A2-17
p31 to inhibit presentationof Ii-depen-
dent epitopes to I-Ad-restricted T cells
as 10% of total Ii from alternative splicing of
bovine ribonuclease ; HEL, hen egg lysozyme ;Discussion
In the present study we have examined the role of the en-
dosomal localization signal located in the cytosolic tail of Ii
in class II transport and antigen presentation. We found that
deletion of amino acids 2-17 from the cytosolic tail of p41
Ii dramatically altered the intracellular transport ofclass II-Ii
complexes. Class II that is associated with wild type Ii exits
the trans-Golgi apparatus and is transported to and retained
for several hourswithin an endosomal compartment. Within
this compartment Ii is degraded and class II is released to
the cell surface. It is during passage through this proteolytic
compartment that newly synthesized class II en route to the
cell surface is thought to associate with antigenic peptides.
Truncation of the Ii cytosolic tail results in the rapid trans-
port of class II-Ii complexes from the trans-Golgi apparatus
to the cell surface. Once at the cell surface the complex is
internalized over time, Ii is degraded, and class II recycles
to the plasma membrane. Surprisingly, altering the pathway
of class II transport in this manner had little effect on the
ability of p41 Ii to enhance antigen presentation. Thus, p41-
dependent enhancement ofantigen presentation does not re-
quire the endosomal localization signal encoded in the cyto-
solic tail of Ii.
Our biochemical data suggest that, when associated with
A2-17 p41, classII intersects the endosomal antigen processing
compartments afterinternalization from the cell surface. The
transport rate to the cell surface of class II associated with
truncated Ii is extremely rapid compared with class II associated
with wild type Ii (41). Thus, in the absence of the Ii-encoded
endosomal localization signal class II is either not sorted to
or is not retained in the endosomal compartment during trans-
port to the cell surface. Dissociation of both wild type and
truncated p41 appears to occurby similar proteolytic events.
However, the kinetics of Ii dissociation and of the appear-
ance ofclass II-associated Ii proteolytic fragments is delayed
in A2-17 p41-positive cell lines, and significant Ii dissocia-
tion occurs only after the class II-02-17 p41 complex has
arrived at the plasma membrane. Thesedata suggest that A2-17
Ii gains access to endosomes via an internalization pathway
from the cell surface which then results in the cleavage and
turnover of the A2-17 Ii molecule. This was substantiated
by a direct measure of class II internalization. Finally, the
half-life of class II is much longer than that of A2-17 p41,
arguing that the internalized class II returns to the cell sur-
face afterA2-17 Ii is degraded. The detection of a large popu-
lation of steady state classII that is free ofIi at the cell surface
supports this observation. Taken together, these analyses of
the effects of A2-17 p41 on classII transport reveal a pathway
of plasma membrane recycling for class II molecules.
Demonstration ofclass II internalization and recycling has
been a controversial issue. Although some early studies were
able to document internalization of class II (17-19), most of
these studies relied on the use of antibodies to tag cell surface
classII molecules, and it has been difficult to control for the
possibility that antibody-binding modulates class II internali-
zation. In several cases where ligand-independent internali-
zation has been measured, little or no internalization has been
1966 Antigen Presentation Mediated by Truncated Ii
detected (41, 43, 44). However, Reid and Watts (45) have
shown that class II endocytosis and recycling can occur in
B cells, but the cycling time is extremely rapid (2-3 min)
and an appreciable pool of internalized class II was not evi-
dent without the use ofprimaquine to neutralize endosomal
compartments. In contrast, the L cell transfectants analyzed
in the present study internalize class II more slowly and an
appreciable pool of intracellular class II (10-20% of total)
can be accumulated afterinternalization from the cell surface.
There is accumulating data showing that the majority of
class II-peptide complexes at the cell surface are derived from
newly synthesized class II binding peptides en route to the
cell surface. The sensitivity of antigen presentation to pro-
tein synthesis inhibitors and brefeldin A (46, 47) implicates
a role for newly synthesized class II. However, the lack of
specificity of these reagents and the recent observation that
brefeldin A can affect endocytosis (48, 49) raise the possi-
bility that these drugs inhibit antigen presentation by modi-
fying cellular functions other than classII biosynthesis. More
recently, the observation that the ability of Langerhans cells
to process and present antigen correlateswith a transient in-
duction of class II biosynthesis (50) and the ability of Ii to
enhance presentation of some antigens (15, 16) argue that
newly synthesized class II may be the principle component
for antigen presentation. This hypothesis has been confirmed
by biochemical analyses ofclassII-peptide association. Newly
synthesized class II has been shown to form SDS-stable con-
formations, indicative of peptide association, while en route
to the cell surface (42, 51). This process can be driven by
both fluid phase uptake of antigen (51) and internalization
of antigen through the immunoglobulin receptor on antigen-
specific B cells (44). These data are consistent with a pre-
dominant role ofde novo synthesized class II in antigen pre-
sentation.
The relative role of plasma membrane recycled class II in
antigen presentation has been more controversial. One of the
strongest arguments for a recycling pathway has been that
the half-life of peptide-class II complexes is relatively short
compared with the half-life of class II molecules (52, 53).
This rapid turnover of peptide-class II complexes in living
cells may allow for peptide exchange and reutilization ofclass
II (54). In light ofthis possibility, dissociation of peptide-class
II complexes appears to occurwithin an acidic compartment
that might represent the peptide loading, endosomal com-
partment (53). In contrast, in EBV-transformed human B
cells class II-peptide complexes are extremely stable and their
turnover rate is similar to total class II, suggesting that in
these cellsthere is no opportunity for peptide exchange (55).
One possible explanation for the apparent disagreement as
to whether classII can be recycled and whether this recycling
component is functionally relevant is that this process may
vary between cell types. Consistent with this possibility, little,
if any, class II internalization has been detected in EBV-
transformed human B cell lines (41, 43, 44), similar to those
that express extremely stable class II-peptide complexes (55).
In addition, expression of class II with Ii containing a cyto-solictail deletion in the human fibroblast cell line, M1, results
in very stable expressionof the class II-Ii complex at the cell
surface and the vast majority of class II remains associated
with Ii (5). This is in contrast to our finding in L cell trans-
fectants that 30-45% of cell surface class II has dissociated
from Ii. This may reflect differences in the ability of these
cell types to internalize class II, allowing for endosomal degra-
dation of Ii. In this report, we show that in the presence
of ii, endocytosed class II can enter the proper endocytic com-
partments for antigen binding. Although we know that Ii-
free class II can still be internalized, it remains to be deter-
mined whether this pool ofrecycling Ii-free class II is capable
of accessing antigenic peptides and whether this pathway exists
in conventional antigen-presenting cells.
Previous studies from our laboratory have indicated that
the p31 form of Ii, which contains a wild type endosomal
localization signal, is not very effective at facilitating antigen
presentation compared to Ii-negative cells (16) . This obser-
vation along with the present study suggest that for some
antigens the endosomal localization signal in the cytosolic
tail of Ii is neither necessary nor sufficient to enhance antigen
presentation. However, it is possible that under some circum-
stances, the ability of the endosomal localization signal to
increase the relative concentration of class II in endosomes
may be important for effective antigen presentation. For ex-
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ample, in cells that express low levels of class II or in B cells
that internalize a bolus ofantigen in a short time, the amount
of class II available for peptide binding in endosomes may
be the limiting factor during antigen presentation. In con-
trast, our L cell transfectants express high levels of class II
and continuously internalize antigen by fluid phase uptake
throughout the courseof the antigen presentation assay. Under
these conditions, the dwell time of class II within endosomal
compartments may not be a critical factor in the efficiency
of antigen presentation.
The results presented in this report suggest that the p41
form ofIi can facilitate antigen presentation regardlessof the
route that class II takes to the endosome. In wild type p41-
positive cells the class II-Ii complex is sorted directly from
the trans-Golgi apparatus to endosomes, where Ii is degraded
and classII associateswith peptide. Deletionof the endosomal
localization signal in Ii results in the rapid transport of the
class II-A2-17 p41 complex to the plasma membrane and Ii
is degraded only after internalization of the complex. Thus,
these data raise the possibility that, in addition to the con-
ventional trans-Golgi apparatus to endosomal route, class II
might form complexes with antigenic peptide when it enters
the endosomal compartment after endocyooeds from the cell
surface.
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